Mátyás, Csaba <br/><br/>
The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus.  [electronic resource] 

 -  Cardiovascular diabetology  Oct 2015 
 - 145 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1475-2840 
<br/><br/><label>Standard No.: </label>10.1186/s12933-015-0309-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzoates--pharmacology<br/>Cyclic GMP--metabolism<br/>DNA Damage--drug effects<br/>Diabetes Mellitus, Experimental--metabolism<br/>Diabetes Mellitus, Type 1--metabolism<br/>Diabetic Cardiomyopathies<br/>Disease Models, Animal<br/>Fibrosis<br/>Heart--drug effects<br/>Immunohistochemistry<br/>In Situ Nick-End Labeling<br/>Myocardium--pathology<br/>Nitric Oxide--metabolism<br/>Rats